Telmisartan

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage

Now that it has been established that the novel coronavirus is going to globally impact the drug s

Teva’s rating cut to junk; Two Lupin facilities receive FDA warning letters

This week in Phispers, we look at the contrasting 2017 forecasts of Mylan and Teva, resulting from t

Will data integrity concerns on clinical trials done at GVK Biosciences go beyond Europe?

 Over 700 commonly used generic medicines were recommended for suspension by the European Medic

Dr. Reddy’s expansion plans for API production

Unrelated to the inspection of the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe